Investigative Urology
Dichloroacetate Prevents Cisplatin-Induced Nephrotoxicity without Compromising Cisplatin Anticancer Properties
March 14, 2016
Lack of association between polymorphisms in the CYP1A2 gene and risk of cancer: evidence from meta-analyses
March 11, 2016
Conditional Expression of the Androgen Receptor Increases Susceptibility of Bladder Cancer in Mice
March 11, 2016
Novel somatic mutations identified by whole-exome sequencing in muscle-invasive transitional cell carcinoma of the bladder
March 11, 2016
Systemic Inflammatory Response Based on Neutrophil-to-Lymphocyte Ratio as a Prognostic Marker in Bladder Cancer
March 11, 2016
CRM1 inhibitor S109 suppresses cell proliferation and induces cell cycle arrest in renal cancer cells
March 11, 2016
Tumor radio-sensitivity assessment by means of volume data and magnetic resonance indices measured on prostate tumor bearing rats
March 11, 2016
Silybin suppresses cell proliferation and induces apoptosis of multiple myeloma cells via the PI3K/Akt/mTOR signaling pathway
March 11, 2016
Functional analysis of the TMPRSS2:ERG fusion gene in cisplatin‑induced cell death.
March 11, 2016
4C-seq revealed long-range interactions of a functional enhancer at the 8q24 prostate cancer risk locus
March 11, 2016
New Insights Into the Mechanism of COP9 Signalosome-Cullin-RING Ubiquitin-Ligase Pathway Deregulation in Urological Cancers
March 11, 2016
Tetrandrine suppresses metastatic phenotype of prostate cancer cells by regulating Akt/mTOR/MMP-9 signaling pathway
March 11, 2016